Definiens and Ultivue Announce a Collaboration to Co-Develop Joint Offerings in Multiplexed Immunofluorescence (IF) and AI Enabled Digital Image Analysis
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens,…